Table 1

Mendelian randomization estimates between blood pressure traits and atrial fibrillation

Inverse-variance weighted methodMaximum likelihoodMR-Egger regressionMedian-based method
InterceptSlope
BP traitΝOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueOR95% CIP-valueOR95% CIP-value
SBP2661.0181.012–1.0241E−08<0.00011.0191.012–1.025<0.001<0.00011.0061.002–1.0100.0060.9980.982–0.0130.7631.0161.009–1.023<0.001
DBP3451.0261.016–1.0351.5E−<0<0.00011.0271.016–1.037<0.001<0.00011.0010.997–1.0050.5971.020.997–1.0430.0831.0211.012–1.030<0.001
PP2831.0141.001–1.0280.033<0.00011.0161.000–1.0310.05<0.00010.9980.993–1.0040.5331.0240.991–1.0580.1581.0151.005–1.0250.004
Inverse-variance weighted methodMaximum likelihoodMR-Egger regressionMedian-based method
InterceptSlope
BP traitΝOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueOR95% CIP-valueOR95% CIP-value
SBP2661.0181.012–1.0241E−08<0.00011.0191.012–1.025<0.001<0.00011.0061.002–1.0100.0060.9980.982–0.0130.7631.0161.009–1.023<0.001
DBP3451.0261.016–1.0351.5E−<0<0.00011.0271.016–1.037<0.001<0.00011.0010.997–1.0050.5971.020.997–1.0430.0831.0211.012–1.030<0.001
PP2831.0141.001–1.0280.033<0.00011.0161.000–1.0310.05<0.00010.9980.993–1.0040.5331.0240.991–1.0580.1581.0151.005–1.0250.004

BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; MR, mendelian randomization; OR, odds ratio; PP, pulse pressure; SBP, systolic blood pressure; SNPs, single-nucleotide polymorphisms; Ν, # of SNPs used in MR.

Table 1

Mendelian randomization estimates between blood pressure traits and atrial fibrillation

Inverse-variance weighted methodMaximum likelihoodMR-Egger regressionMedian-based method
InterceptSlope
BP traitΝOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueOR95% CIP-valueOR95% CIP-value
SBP2661.0181.012–1.0241E−08<0.00011.0191.012–1.025<0.001<0.00011.0061.002–1.0100.0060.9980.982–0.0130.7631.0161.009–1.023<0.001
DBP3451.0261.016–1.0351.5E−<0<0.00011.0271.016–1.037<0.001<0.00011.0010.997–1.0050.5971.020.997–1.0430.0831.0211.012–1.030<0.001
PP2831.0141.001–1.0280.033<0.00011.0161.000–1.0310.05<0.00010.9980.993–1.0040.5331.0240.991–1.0580.1581.0151.005–1.0250.004
Inverse-variance weighted methodMaximum likelihoodMR-Egger regressionMedian-based method
InterceptSlope
BP traitΝOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueP-value for heterogeneityOR95% CIP-valueOR95% CIP-valueOR95% CIP-value
SBP2661.0181.012–1.0241E−08<0.00011.0191.012–1.025<0.001<0.00011.0061.002–1.0100.0060.9980.982–0.0130.7631.0161.009–1.023<0.001
DBP3451.0261.016–1.0351.5E−<0<0.00011.0271.016–1.037<0.001<0.00011.0010.997–1.0050.5971.020.997–1.0430.0831.0211.012–1.030<0.001
PP2831.0141.001–1.0280.033<0.00011.0161.000–1.0310.05<0.00010.9980.993–1.0040.5331.0240.991–1.0580.1581.0151.005–1.0250.004

BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; MR, mendelian randomization; OR, odds ratio; PP, pulse pressure; SBP, systolic blood pressure; SNPs, single-nucleotide polymorphisms; Ν, # of SNPs used in MR.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close